Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BIONn | Xetra | EUR | Delayed | |
BBZAd | BATS Europe | EUR | Delayed | |
BIONz | BATS Europe | CHF | Delayed | |
0JYO | London | CHF | Real-time | |
BION | Switzerland | CHF | Delayed | |
BIONn | Frankfurt | EUR | Delayed |
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Name | Age | Since | Title |
---|---|---|---|
Thomas von Planta | 63 | 2019 | Member of the Board of Directors |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review